STAT

Opinion: With only ‘shaky data’ to go on, it’s tough to practice evidence-based medicine during the Covid-19 pandemic

Part of my job as an obstetrician is to keep up with the latest evidence so I can provide the best care for my patients. But I’ve never felt as dependent as I am today on shaky data to make what could be life or death decisions.

In a normal month, I receive a stack of medical journals to leaf through and actively seek out new reports online. I focus my attention on the most rigorous studies, those most likely to draw conclusions we can be confident in. These generally include

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks